Piper Sandler reaffirmed its Overweight rating on DexCom (NASDAQ:DXCM) stock, maintaining a price target of $90.00. The firm's analysts highlighted several positive developments for the medical device ...
Microsoft will stop supporting Office apps on Windows 10 this year. Also it really wants you to upgrade to Windows 11.